GO
Loading...

Express Scripts Holding Co

More

  • Dec 22- The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount. Express Scripts' move reignited investor concerns that pharmaceutical companies...

  • Midday Glance: Drug Benefits companies Monday, 22 Dec 2014 | 1:22 PM ET

    NEW YORK— Shares of some top drug benefits companies are up at 1 p.m.:. CVSCaremark rose $1.26 or 1.3 percent, to $96.96. Express Scripts Holding Co. rose $1.07 or 1.3 percent, to $82.04.

  • *Gilead falls as Express Scripts picks AbbVie treatment. *Dow boosted by gains at Intel, IBM. The S&P energy index fell 1.6 percent as the day's weakest sector; Chevron Corp lost 1.3 percent to $111.44 while Halliburton Co was off 1.9 percent at $39.70.

  • Gilead falls as Express Scripts picks AbbVie treatment. Express Scripts, the nation's largest pharmacy benefit manager, said it would no longer cover Gilead's treatments after it lined up a cheaper price from AbbVie Inc for its newly approved hepatitis C treatment. "That is very specific to Gilead, so that one is getting crushed, but it shouldn't necessarily set...

  • Dec 22- The nation's largest pharmacy benefit manager has lined up a cheaper price from AbbVie Inc on its newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc treatments, Express Scripts said on Monday. Express Scripts has opposed the $84,000 pricetag of Gilead Sciences' Sovaldi treatment since it was approved a year...

  • Early Glance: Drug Benefits companies Monday, 22 Dec 2014 | 10:22 AM ET

    NEW YORK— Shares of some top drug benefits companies are up at 10 a.m.:. CVSCaremark rose$. 93 or 1.0 percent, to $96.63. Express Scripts Holding Co. rose$. 86 or 1.1 percent, to $81.83.

  • *Gilead falls as Express Scripts picks AbbVie treatment. NEW YORK, Dec 22- U.S. stocks were modestly higher on Monday, after the benchmark S&P 500 notched its best weekly performance in nearly two months, as a sharp drop in Gilead Sciences reined in broader gains. Express Scripts, the nation's largest pharmacy benefit manager, has lined up a cheaper price from AbbVie...

  • *Gilead falls as Express Scripts picks AbbVie treatment. Brent last traded down 26 cents at $61.12 while U.S. crude was last off 0.6 percent at $56.77 after Saudi Arabia indicated it could increase its output. "Oil is in the process of bottoming out here," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York.

  • *Gilead falls as Express Scripts chooses AbbVie treatment. NEW YORK, Dec 22- U.S. stock index futures advanced on Monday, after the S&P 500 notched its best weekly performance in almost two months, ahead of data on the housing market. Brent last traded down 21 cents at $61.17 while U.S. crude was last off 0.7 percent at $56.74 after Saudi Arabia indicated it could...

  • Express Scripts said Monday that it will no longer cover Sovaldi and Harvoni— two Gilead Sciences drugs that cost more than $80,000 each for a full course of treatment— or Johnson& Johnson's Olysio starting Jan. 1, except under limited circumstances. Instead, it will make AbbVie Inc.' s Viekira Pak, approved only Friday, the preferred treatment for patients who have...

  • US STOCKS-Futures climb after three-day run Monday, 22 Dec 2014 | 7:45 AM ET

    *Gilead falls as Express Scripts chooses AbbVie treatment. NEW YORK, Dec 22- U.S. stock index futures advanced on Monday, after the S&P 500 notched its best weekly performance in almost two months, as oil prices continued to show signs of stabilizing. However, Brent pulled back to last trade down 14 cents to $61.24 while U.S. crude was last off 0.4 percent at $56.91.

  • US stock indexes drift higher in afternoon trading Monday, 22 Dec 2014 | 2:13 AM ET

    Stocks moved slightly higher in afternoon trading Monday, on pace to build modestly on gains from last week. KEEPING SCORE: The Dow Jones industrial average rose 103 points, or 0.5 percent, to 17,908 as of 1:14 p.m. Eastern time. THE QUOTE: "With the Dow being up substantially more than the S&P 500, I would tend to say what's holding back the S&P is more related to its...

  • Final Glance: Drug Benefits companies Friday, 19 Dec 2014 | 6:41 PM ET

    NEW YORK— Shares of some top drug benefits companies were up at the close of trading:. CVSCaremark rose$. 18 or. 2 percent, to $95.70. Express Scripts Holding Co. rose$. 49 or. 6 percent, to $80.97.

  • Midday Glance: Drug Benefits companies Friday, 19 Dec 2014 | 1:25 PM ET

    NEW YORK— Shares of some top drug benefits companies are up at 1 p.m.:. CVSCaremark rose$. 12 or. 1 percent, to $95.64. Express Scripts Holding Co. rose$. 83 or 1.0 percent, to $81.31.

  • Early Glance: Drug Benefits companies Friday, 19 Dec 2014 | 10:20 AM ET

    NEW YORK— Shares of some top drug benefits companies are up at 10 a.m.:. CVSCaremark rose$. 33 or. 3 percent, to $95.85. Express Scripts Holding Co. rose$. 54 or. 7 percent, to $81.02.

  • Final Glance: Drug Benefits companies Thursday, 18 Dec 2014 | 8:08 PM ET

    NEW YORK— Shares of some top drug benefits companies were up at the close of trading:. CVSCaremark rose $1.35 or 1.4 percent, to $95.52. Express Scripts Holding Co. rose$. 54 or. 7 percent, to $80.48.

  • Midday Glance: Drug Benefits companies Thursday, 18 Dec 2014 | 1:48 PM ET

    NEW YORK— Shares of some top drug benefits companies are up at 1 p.m.:. CVSCaremark rose$. 53 or. 6 percent, to $94.70. Express Scripts Holding Co. rose$. 24 or. 3 percent, to $80.18.

  • Early Glance: Drug Benefits companies Thursday, 18 Dec 2014 | 11:11 AM ET

    NEW YORK— Shares of some top drug benefits companies are up at 10 a.m.:. CVSCaremark rose$. 53 or. 6 percent, to $94.70. Express Scripts Holding Co. rose$. 27 or. 3 percent, to $80.21.

  • Final Glance: Drug Benefits companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    NEW YORK— Shares of some top drug benefits companies were up at the close of trading:. CVSCaremark rose $1.86 or 2.0 percent, to $94.17. Express Scripts Holding Co. rose$. 49 or. 6 percent, to $79.94.

  • Midday Glance: Drug Benefits companies Wednesday, 17 Dec 2014 | 1:17 PM ET

    NEW YORK— Shares of some top drug benefits companies are mixed at 1 p.m.:. CVSCaremark rose $1.28 or 1.4 percent, to $93.59. Express Scripts Holding Co. fell$. 03 or percent, to $79.42.